Is it possible to use a genetic test to predict an individual’s risk of severe infection requiring hospitalization or death from SARS-CoV-2? That is the claim of Australian-based molecular diagnostics company Genetic Technologies Limited. It recently announced an agreement with U.S.-based Infinity BiologiX LLC (IBX) to sell its “COVID-19 Severe Disease Risk Test” to consumers …
June 14, 2021 Intelligence: Late-Breaking Lab News Read More »
